Tilganga Institute of Ophthalmology, Gausala, Nepal.
School of Optometry and Vision Science, Queensland University of Technology, Brisbane, Queensland, Australia.
Ophthalmic Physiol Opt. 2021 May;41(3):610-622. doi: 10.1111/opo.12796. Epub 2021 Mar 9.
Spectacle non-tolerance or adverse events to spectacle wear are serious concerns for both patients and practitioners. Non-tolerance may contribute to a negative impact on the practitioner's ability and practice. Therefore, a detailed understanding of frequency and causes of spectacle non-tolerance in clinical ophthalmic practice is essential. This review aimed to determine the prevalence and causes of non-tolerance to spectacles prescribed and dispensed in clinical practice.
The current systematic review included quantitative studies published in the English language that reported spectacle non-tolerance in clinical practice. A comprehensive search was conducted in PubMed, Scopus and the Web of Science database for studies published until 13 July 2020. An adapted version of the Newcastle-Ottawa Scale (NOS) modified for cross-sectional studies was used to assess the quality of each included study. Five investigations with 205,478 study participants were included in the review. The prevalence of spectacle non-tolerance from individual studies was pooled using MetaXL software. The pooled prevalence of spectacle non-tolerance was 2.1% (95% CI: 1.6-2.7) ranging from 1.6% to 3.0%. The papers were also reviewed to identify the potential causes of non-tolerances. Nearly half reported that non-tolerance (47.4%) was due to an error in refraction. Other causes identified were errors related to communication (16.3%), dispensing (13.5%), non-adaptation (9.7%), data entry (8.7%), binocular vision (7.4%) and ocular pathology (6.4%).
This review improves our understanding of spectacle non-tolerance in clinical practice. This is important because non-tolerance may lead to spectacle wear discontinuation, which may deprive patients of optimal vision. Increased non-tolerance in clinical practice may affect a clinician's reputation and incur additional costs associated with reassessments and replacements. Spectacle non-tolerance occurred due to a multitude of factors related to optical dispensing and wearer adaptation. Therefore, there is a need for vigilance while prescribing spectacles. The limited evidence highlights the need for more studies, especially in limited-resource settings, to improve the quality of refractive error services.
眼镜佩戴不适或不良反应是患者和医生都非常关注的问题。不耐受可能会对医生的能力和实践产生负面影响。因此,详细了解临床眼科实践中眼镜不耐受的频率和原因至关重要。本综述旨在确定在临床实践中开具和配眼镜时眼镜不耐受的发生率和原因。
本系统综述包括以英文发表的定量研究,报告了临床实践中眼镜不耐受的情况。在 PubMed、Scopus 和 Web of Science 数据库中全面检索了截至 2020 年 7 月 13 日发表的研究。使用针对横断面研究修改的纽卡斯尔-渥太华量表(NOS)评估纳入研究的质量。使用 MetaXL 软件汇总来自单个研究的眼镜不耐受发生率。汇总的眼镜不耐受发生率为 2.1%(95%CI:1.6-2.7),范围为 1.6%-3.0%。综述还对潜在的不耐受原因进行了审查。近一半的论文报告说,不耐受(47.4%)是由于验光错误引起的。其他确定的原因包括与沟通(16.3%)、配镜(13.5%)、不适应(9.7%)、数据录入(8.7%)、双眼视觉(7.4%)和眼部病理(6.4%)相关的错误。
本综述提高了我们对临床实践中眼镜不耐受的认识。这很重要,因为不耐受可能导致眼镜佩戴中断,从而使患者无法获得最佳视力。临床实践中不耐受率的增加可能会影响医生的声誉,并带来与重新评估和更换相关的额外成本。眼镜不耐受是由与光学配镜和佩戴者适应相关的多种因素引起的。因此,在配眼镜时需要保持警惕。有限的证据强调需要进行更多的研究,特别是在资源有限的环境中,以提高屈光不正服务的质量。